Avelumab—a new programmed death-ligand 1 inhibitor against...

Translational Lung Cancer Research 2017 / 12 Vol. 6; Iss. S1

Avelumab—a new programmed death-ligand 1 inhibitor against advanced non-small cell lung cancer

Gil-Bazo, Ignacio
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Translational Lung Cancer Research
DOI:
10.21037/tlcr.2017.11.01
Date:
December, 2017
File:
PDF, 130 KB
english, 2017
Conversion to is in progress
Conversion to is failed